首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1775324

2025-2030 年全球組織移植市場預測

Global Tissue Transplant Market - Forecasts from 2025 to 2030

出版日期: 2025年06月23日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

組織移植市場預計將從 2025 年的 100.16 億美元成長到 2030 年的 143.91 億美元，複合年成長率為 7.52%。

由於慢性病的盛行率不斷上升、健康意識的不斷增強以及技術的進步，組織移植市場正在經歷顯著成長。組織移植（移植物）是指將組織從一個部位移植到同一個體或不同個體的另一個部位，以恢復因糖尿病、癌症、心血管疾病、阿茲海默症症等疾病而嚴重受損的器官或組織的功能。由於這些慢性疾病通常會導致不可逆的組織損傷，因此移植已成為重獲健康生活的重要解決方案。

市場促進因素

慢性疾病和傷害案例增加

慢性病的激增增加了永久性組織損傷的風險，從而刺激了組織移植的需求。常見的手術包括皮膚、角膜、骨骼、心臟瓣膜、肌腱、神經、靜脈等移植。燒燙傷和損傷病例的增加進一步推動了市場的發展。例如，歐洲道路安全觀察站2023年的研究報告顯示，西班牙發生了102,362起傷害事故，凸顯了組織移植治療此類損傷的必要性。

皮膚移植

由於燒燙傷、酸損傷、皮膚癌、糖尿病和其他疾病的發生率不斷上升，皮膚移植領域預計將佔據重要的市場佔有率。皮膚移植透過從患者身體的某部位切取小塊皮膚，並將其移植到受損區域，可以有效地治療大面積損傷。全球範圍內這些疾病的發病率上升推動了該領域的成長。

同種異體移植段的生長

異基因移植領域涉及不同物種個體之間的組織和器官移植，預計將以顯著的複合年成長率成長。異基因移植產品改善患者預後以及市場參與企業的策略性擴張是關鍵促進因素。雖然目前尚無2023年後的案例，但對擴大異體移植產品供應的關注將持續支持該領域的成長。

技術進步

移植技術的進步預計將透過改善治療效果和提高可及性來刺激市場擴張。這些創新為改善治療效果和更廣泛地應用組織移植創造了機會。

市場挑戰

儘管組織移植市場潛力巨大，但它仍面臨移植排斥等挑戰，這成為其廣泛應用的主要障礙。此外，部分地區對組織移植的認知度較低，也限制了市場擴張。

地理視角

北美預計將主導組織移植市場，這得益於其先進的醫療基礎設施和主要行業參與者的參與。歐洲是第二大市場，得益於高額的研發投入和龐大的病患群。預計這些因素將在預測期內維持該地區的成長。

隨著慢性病盛行率上升、技術進步以及損傷相關需求的增加，組織移植市場預計將持續成長。然而，要充分發揮市場潛力，需要解決移植排斥反應和認知差距等挑戰。在強大的醫療保健體系和持續的技術創新的支持下，北美和歐洲預計將引領這一趨勢。

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
適用範圍廣：對於新興企業、科學研究機構、顧問公司、中小企業、大型企業都有利且划算。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
各細分市場和地區（包括國家）的收益成長和預測分析

公司簡介

The global tissue transplant market is experiencing significant growth driven by the increasing prevalence of chronic diseases, rising health awareness, and technological advancements. Tissue transplants, or grafts, involve transferring tissue from one location to another within the same or different individuals to restore functionality in cases of severe organ or tissue damage caused by conditions such as diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer's disease. These chronic conditions often lead to irreversible tissue damage, making transplantation a critical solution for restoring a healthy life.

Market Drivers

Rising Chronic Diseases and Injury Cases

The surge in chronic diseases has heightened the risk of permanent tissue damage, increasing the demand for tissue transplants. Commonly performed procedures include transplants of skin, cornea, bones, heart valves, tendons, nerves, and veins. The market is further propelled by a growing number of burn and injury cases. For instance, a 2023 European Road Safety Observatory study reported 102,362 injury accidents in Spain, underscoring the need for tissue transplantation to address such injuries.

Skin Transplantation

The skin transplant segment is anticipated to hold a significant market share due to the rising incidence of burns, acid injuries, and conditions like skin cancer and diabetes. Skin grafting involves harvesting a small patch of skin from one part of a patient's body and transplanting it to the damaged area, effectively treating extensive injuries. This segment's growth is driven by the increasing prevalence of these conditions globally.

Allograft Segment Growth

The allograft segment, involving the transplantation of tissue or organs between non-identical individuals of the same species, is projected to grow at a significant compound annual growth rate (CAGR). Improved patient outcomes from allograft products and strategic expansions by market players are key drivers. While no specific post-2023 examples are available, the focus on expanding allograft product offerings continues to support this segment's growth.

Technological Advancements

Advancements in transplant technologies are expected to fuel market expansion by improving procedure outcomes and accessibility. These innovations create opportunities for enhanced treatment efficacy and broader adoption of tissue transplantation.

Market Challenges

Despite its growth potential, the tissue transplant market faces challenges, including transplant rejection, which remains a significant barrier to widespread adoption. Additionally, limited awareness about tissue transplantation in certain regions restricts market expansion.

Geographical Outlook

North America is expected to dominate the tissue transplant market due to its advanced healthcare infrastructure and the presence of key industry players. Europe follows as the second-largest market, driven by substantial investments in research and development and a large patient population. These factors are anticipated to sustain regional growth over the forecast period.

The tissue transplant market is poised for growth, driven by rising chronic disease prevalence, technological advancements, and increasing injury-related demand. However, challenges like transplant rejection and awareness gaps must be addressed to fully realize the market's potential. North America and Europe are expected to lead, supported by robust healthcare systems and ongoing innovation.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Tissue Transplant Market Segmentation

By Tissue Type

Cornea
Skin
Bone Marrow
Others

By Graft Type

Autograft
Allograft
Xenograft

By End-User

Hospitals
Surgical Centers
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
Japan
India
South Korea
Indonesia
Thailand
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL TISSUE TRANSPLANT MARKET BY TISSUE TYPE

5.1. Introduction
5.2. Cornea
5.3. Skin
5.4. Bone Marrow
5.5. Others

6. GLOBAL TISSUE TRANSPLANT MARKET BY GRAFT TYPE

6.1. Introduction
6.2. Autograft
6.3. Allograft
6.4. Xenograft

7. GLOBAL TISSUE TRANSPLANT MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Surgical Centers
7.4. Others

8. GLOBAL TISSUE TRANSPLANT MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others